Increased	increased	O	O	O	O
mental	mental	O	O	OTHERS	I
slowing	slowing	O	O	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
APOE	apoe	O	O	O	O
epsilon4	epsilon4	O	O	O	O
allele	allele	O	O	O	O
after	after	O	O	O	O
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
oral	oral	O	O	O	O
anticholinergic	anticholinergic	O	O	O	O
challenge	challenge	O	O	O	O
in	in	O	O	O	O
healthy	healthy	O	O	O	O
elderly	elderly	O	O	O	O
.	.	O	O	O	O

OBJECTIVES	objectives	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
objectives	objectives	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
were	were	O	O	O	O
to	to	O	O	O	O
examine	examine	O	O	O	O
the	the	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
APOE	apoe	O	O	O	O
epsilon4	epsilon4	O	O	O	O
and	and	O	O	O	O
subjective	subjective	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
measures	measures	O	O	O	O
reflecting	reflecting	O	O	O	O
sedation	sedation	O	O	O	O
and	and	O	O	O	O
confusion	confusion	O	DISEASE	OTHERS	I
and	and	O	O	O	O
to	to	O	O	O	O
investigate	investigate	O	O	O	O
the	the	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
trihexyphenidyl-induced	trihexyphenidyl-induced	O	O	O	O
subjective	subjective	O	O	O	O
effects	effects	O	O	O	O
and	and	O	O	O	O
objective	objective	O	O	O	O
memory	memory	O	O	O	O
performance	performance	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
This	this	O	O	O	O
study	study	O	O	O	O
comprised	comprised	O	O	O	O
24	24	O	O	O	O
cognitively	cognitively	O	O	O	O
intact	intact	O	O	O	O
,	,	O	O	O	O
health	health	O	O	O	O
elderly	elderly	O	O	O	O
adults	adults	O	O	O	O
(	(	O	O	O	O
12	12	O	O	O	O
APOE	apoe	O	O	O	O
epsilon4	epsilon4	O	O	O	O
carriers	carriers	O	O	O	O
)	)	O	O	O	O
at	at	O	O	O	O
an	an	O	O	O	O
outpatient	outpatient	O	O	O	O
geriatric	geriatric	O	O	O	O
psychiatry	psychiatry	O	O	O	O
research	research	O	O	O	O
clinic	clinic	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
was	was	O	O	O	O
a	a	O	O	O	O
randomized	randomized	O	O	O	O
,	,	O	O	O	O
double	double	O	O	O	O
blind	blind	O	O	OTHERS	I
,	,	O	O	O	O
placebo-controlled	placebo-controlled	O	O	O	O
,	,	O	O	O	O
three-way	three-way	O	O	O	O
,	,	O	O	O	O
crossover	crossover	O	O	O	O
experimental	experimental	O	O	O	O
design	design	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
participants	participants	O	O	O	O
received	received	O	O	O	O
1.0	1.0	O	O	O	O
mg	mg	O	O	OTHERS	I
or	or	O	O	O	O
2.0	2.0	O	O	O	O
mg	mg	O	O	OTHERS	I
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
placebo	placebo	O	O	O	O
administered	administered	O	O	O	O
in	in	O	O	O	O
counterbalanced	counterbalanced	O	O	O	O
sequences	sequences	O	O	O	O
over	over	O	O	O	O
a	a	O	O	O	O
period	period	O	O	O	O
of	of	O	O	O	O
three	three	O	O	O	O
consecutive	consecutive	O	O	O	O
weeks	weeks	O	O	O	O
.	.	O	O	O	O

Bond	bond	O	O	O	O
and	and	O	O	O	O
Lader	lader	O	O	O	O
's	's	O	O	O	O
visual	visual	O	O	O	O
analog	analog	O	O	O	O
scales	scales	O	O	O	O
and	and	O	O	O	O
alternate	alternate	O	O	O	O
versions	versions	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
Buschke	buschke	O	O	O	O
Selective	selective	O	O	O	O
Reminding	reminding	O	O	O	O
Test	test	O	O	O	O
were	were	O	O	O	O
administered	administered	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
repeated	repeated	O	O	O	O
measures	measures	O	O	O	O
design	design	O	O	O	O
at	at	O	O	O	O
baseline	baseline	O	O	O	O
,	,	O	O	O	O
1	1	O	O	O	O
,	,	O	O	O	O
2.5	2.5	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
5	5	O	O	O	O
hours	hours	O	O	O	O
postdrug	postdrug	O	O	O	O
administration	administration	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
2.0-mg	2.0-mg	O	O	O	O
oral	oral	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
resulted	resulted	O	O	O	O
in	in	O	O	O	O
increased	increased	O	O	O	O
subjective	subjective	O	O	O	O
ratings	ratings	O	O	O	O
of	of	O	O	O	O
mental	mental	O	O	OTHERS	I
slowness	slowness	O	O	OTHERS	I
in	in	O	O	O	O
carriers	carriers	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
APOE	apoe	O	O	O	O
epsilon4	epsilon4	O	O	O	O
allele	allele	O	O	O	O
only	only	O	O	O	O
.	.	O	O	O	O

Drug	drug	O	O	O	O
effects	effects	O	O	O	O
as	as	O	O	O	O
determined	determined	O	O	O	O
by	by	O	O	O	O
difference	difference	O	O	O	O
scores	scores	O	O	O	O
between	between	O	O	O	O
2.0	2.0	O	O	O	O
mg	mg	O	O	OTHERS	I
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
placebo	placebo	O	O	O	O
on	on	O	O	O	O
ratings	ratings	O	O	O	O
of	of	O	O	O	O
mental	mental	O	O	OTHERS	I
slowness	slowness	O	O	OTHERS	I
significantly	significantly	O	O	O	O
correlated	correlated	O	O	O	O
with	with	O	O	O	O
total	total	O	O	O	O
and	and	O	O	O	O
delayed	delayed	O	O	O	O
recall	recall	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
Buschke	buschke	O	O	O	O
Selective	selective	O	O	O	O
Reminding	reminding	O	O	O	O
Test	test	O	O	O	O
in	in	O	O	O	O
carriers	carriers	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
APOE	apoe	O	O	O	O
epsilon4	epsilon4	O	O	O	O
allele	allele	O	O	O	O
only	only	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
no	no	O	O	O	O
significant	significant	O	O	O	O
effects	effects	O	O	O	O
were	were	O	O	O	O
found	found	O	O	O	O
with	with	O	O	O	O
other	other	O	O	O	O
visual	visual	O	O	O	O
analog	analog	O	O	O	O
scales	scales	O	O	O	O
reflecting	reflecting	O	O	O	O
subjective	subjective	O	O	O	O
sedation	sedation	O	O	O	O
and	and	O	O	O	O
clear-headedness	clear-headedness	O	O	O	O
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
epsilon4	epsilon4	O	O	O	O
allele	allele	O	O	O	O
in	in	O	O	O	O
healthy	healthy	O	O	O	O
elderly	elderly	O	O	O	O
was	was	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
increased	increased	O	O	O	O
subjective	subjective	O	O	O	O
mental	mental	O	O	OTHERS	I
slowing	slowing	O	O	OTHERS	I
after	after	O	O	O	O
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
anticholinergic	anticholinergic	O	O	O	O
challenge	challenge	O	O	O	O
.	.	O	O	O	O

